| Name | Walgreens #18977 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 48 Congress St, Morrisville, Vermont 05661 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (802) 888-2226 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Recent study published in the International Journal of Surgery investigates tested applicability of Google Glass in daily pediatric surgical practice
Medivir AB announced today that the Russian Ministry of Health has approved Sovriad (simeprevir) for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adults with compensated liver disease (including cirrhosis) who are treatment naïve or who have failed previous interferon therapy (pegylated or non-pegylated) with or without ribavirin. Russia will be the first country within EMEA to gain access to simeprevir, which represents a significant advance in hepatitis C treatment.
With cancer, researchers don't believe "you are what you eat"; that disease is always a direct result of what is, or what isn't, on your dinner plate.
Nearly 90 percent of medical journals with relatively high impact factors have policies addressing author conflict of interest (COI) available for public review, according to a report in the November 25 issue of JAMA. But many journals do not require authors to sign disclosure statements, and there is variability in how COI is defined.
› Verified 6 days ago
| NPI Number | 1558885111 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #18977 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 48 Congress St, Morrisville, VT 05661 |
| Phone Number | 802-888-2226 |
News Archive
Recent study published in the International Journal of Surgery investigates tested applicability of Google Glass in daily pediatric surgical practice
Medivir AB announced today that the Russian Ministry of Health has approved Sovriad (simeprevir) for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adults with compensated liver disease (including cirrhosis) who are treatment naïve or who have failed previous interferon therapy (pegylated or non-pegylated) with or without ribavirin. Russia will be the first country within EMEA to gain access to simeprevir, which represents a significant advance in hepatitis C treatment.
With cancer, researchers don't believe "you are what you eat"; that disease is always a direct result of what is, or what isn't, on your dinner plate.
Nearly 90 percent of medical journals with relatively high impact factors have policies addressing author conflict of interest (COI) available for public review, according to a report in the November 25 issue of JAMA. But many journals do not require authors to sign disclosure statements, and there is variability in how COI is defined.
› Verified 6 days ago
News Archive
Recent study published in the International Journal of Surgery investigates tested applicability of Google Glass in daily pediatric surgical practice
Medivir AB announced today that the Russian Ministry of Health has approved Sovriad (simeprevir) for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adults with compensated liver disease (including cirrhosis) who are treatment naïve or who have failed previous interferon therapy (pegylated or non-pegylated) with or without ribavirin. Russia will be the first country within EMEA to gain access to simeprevir, which represents a significant advance in hepatitis C treatment.
With cancer, researchers don't believe "you are what you eat"; that disease is always a direct result of what is, or what isn't, on your dinner plate.
Nearly 90 percent of medical journals with relatively high impact factors have policies addressing author conflict of interest (COI) available for public review, according to a report in the November 25 issue of JAMA. But many journals do not require authors to sign disclosure statements, and there is variability in how COI is defined.
› Verified 6 days ago
Hannaford Food & Drug #8162 Type: Durable Medical Equipment & Medical Supplies Supplier Location: Rte 100 80 Fairground Plaza, Morrisville, Vermont 05661 Phone: (802) 888-9894 | |
Walgreens #18977 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 48 Congress St, Morrisville, Vermont 05661 Phone: (802) 888-2226 | |
Kinney Drugs #23 Type: Pharmacy Location: 97 Morrisville Plz, Morrisville, Vermont 05661 Phone: (802) 888-5244 |